Clinical Trials Directory

Trials / Completed

CompletedNCT06047145

Evaluation of Soy Isoflavones on Skin Ageing Parameters

Evaluation of Oral Soy Isoflavone Concentrates on Skin Ageing Parameters: a Double-blind Randomised Placebo-controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
The Archer-Daniels-Midland Company · Industry
Sex
Female
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

This double-blind, placebo-controlled, randomised pilot trial aims to assess the effect of oral soy isoflavone consumption on skin ageing parameters in post-menopausal women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTsoy isoflavones1 capsule daily for 84 days
DIETARY_SUPPLEMENTPlacebo1 capsule daily for 84 days

Timeline

Start date
2023-10-27
Primary completion
2024-02-26
Completion
2024-02-26
First posted
2023-09-21
Last updated
2025-04-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06047145. Inclusion in this directory is not an endorsement.

Evaluation of Soy Isoflavones on Skin Ageing Parameters (NCT06047145) · Clinical Trials Directory